ARCADIA
To determine if apixaban is superior to aspirin for the prevention of recurrent stroke in patients with cryptogenic ischemic stroke and atrial cardiopathy, and to determine if the relative efficacy of apixaban over aspirin increases with the severity of atrial cardiopathy.